In response to some scientists’ concerns about the rush to patent DNA segments, the U.S. Patent and Trademark Office (PTO) on Dec. 21 posted a new set of proposed examinations guidelines on its Web site.
Jeffrey P. Kushan, a partner in the Washington, D.C., office of Atlanta’s Powell, Goldstein, Frazer & Murphy L.L.P., said that these new utility guidelines should catch the attention of scientists and academics who espouse the purist view that very small DNA segments shouldn’t be patented.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]